Acute Plasma Abeta Responses to Stress

Description

Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined. In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.

Conditions

Stress Reaction, Stress Physiology

Study Overview

Study Details

Study overview

Research has shown that activation of the sympathetic nervous system for extended periods or during certain times in life can increase the risk for Alzheimer's disease. Some research in animal models show that acute activation of the sympathetic nervous system through stress exposure can increase certain Alzheimer's disease-related biomarkers, such as amyloid-beta, within hours of exposure. However, how acute sympathetic nervous system activation via stress exposure affects amyloid-beta levels in humans has yet to be examined. In this study, the investigators will examine whether brief increases in sympathetic activation result in immediate changes in plasma amyloid-beta levels in the five hours after exposure.

Effects of Acute Stress Exposure on Plasma Beta-amyloid Levels

Acute Plasma Abeta Responses to Stress

Condition
Stress Reaction
Intervention / Treatment

-

Contacts and Locations

Los Angeles

University of Southern California, Los Angeles, California, United States, 90089

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Healthy adult weighing at least 110 pounds
  • * No chronic conditions or illness
  • * Taking no medications or drugs that might alter the stress response (e.g., corticosteroids, beta-blockers, and others)
  • * Not using any hormone-containing medication (e.g., hormonal contraceptives, hormone replacement, etc.)
  • * No contraindications for cold pressor test exposure (high blood pressure, heart disease, dysrhythmia, peripheral vascular disease, any other cardiovascular disorder, diabetes, vasculitis, lupus, tingling or numbness in the hands and/or feet, cryoglobulinemia, and Reynaud's phenomenon)
  • * No history of fainting during blood draws
  • * No phobia of having their blood drawn
  • * No general history of fainting or seizures
  • * Not currently diagnosed with a mood disorder (e.g., major depressive disorder)
  • * Not pregnant in the past 12 months
  • * Not lactating in the past 12 months
  • * Not trying to become pregnant if premenopausal
  • * Experienced natural menopause if postmenopausal
  • * Be non-smokers
  • * Be fluent in English

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of Southern California,

Study Record Dates

2024-12